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MDM2 prevents spontaneous tubular epithelial cell
death and acute kidney injury
Dana Thomasova*,1, Martrez Ebrahim1, Kristina Fleckinger1, Moying Li1, Jakob Molnar1, Bastian Popper2, Helen Liapis3,
Ahmed M Kotb4,5, Florian Siegerist4, Nicole Endlich4 and Hans-Joachim Anders1
Murine double minute-2 (MDM2) is an E3-ubiquitin ligase and the main negative regulator of tumor suppressor gene p53. MDM2 has
also a non-redundant function as a modulator of NF-kB signaling. As such it promotes proliferation and inflammation. MDM2 is
highly expressed in the unchallenged tubular epithelial cells and we hypothesized that MDM2 is necessary for their survival and
homeostasis. MDM2 knockdown by siRNA or by genetic depletion resulted in demise of tubular cells in vitro. This phenotype was
completely rescued by concomitant knockdown of p53, thus suggesting p53 dependency. In vivo experiments in the zebrafish model
demonstrated that the tubulus cells of the larvae undergo cell death after the knockdown of mdm2. Doxycycline-induced deletion of
MDM2 in tubular cell-specific MDM2-knockout mice Pax8rtTa-cre; MDM2f/f caused acute kidney injury with increased plasma
creatinine and blood urea nitrogen and sharp decline of glomerular filtration rate. Histological analysis showed massive swelling of
renal tubular cells and later their loss and extensive tubular dilation, markedly in proximal tubules. Ultrastructural changes of tubular
epithelial cells included swelling of the cytoplasm andmitochondria with the loss of cristae and their transformation in the vacuoles.
The pathological phenotype of the tubular cell-specific MDM2-knockout mouse model was completely rescued by co-deletion of
p53. Tubular epithelium compensates only partially for the cell loss caused by MDM2 depletion by proliferation of surviving tubular
cells, with incomplete MDM2 deletion, but rather mesenchymal healing occurs. We conclude that MDM2 is a non-redundant survival
factor for proximal tubular cells by protecting them from spontaneous p53 overexpression-related cell death.
Cell Death and Disease (2016) 7, e2482; doi:10.1038/cddis.2016.390; published online 24 November 2016
Renal tubular epithelial cells are continuously exposed to
stress due to the hypoxia, hyperosmolarity and toxins
exposure and it is rather remarkable that they can withstand
those insults and still execute their physiological functions
that is, water and solutes reabsorption and excretion. Acute
exposures can lead to acute tubular necrosis underlying the
clinical syndrome of acute kidney injury. In unchallenged
kidneys, tubular epithelial cells divide at a very low rate. This
minimal production of new cells supplies though enough
tubular cells to balance the loss of the tubular epithelial cells
into urine and guarantees the physiological turnover of tubule
cells. Nevertheless, this turnover rate must be strictly
controlled as even a small disproportion between cell death
and cell proliferation would eventually result in nephron loss or
significant increase in nephron size.1,2 In unstressed kidney
remain the tubular cells in G0–G1, quiescent state.3 The
mechanisms and factors necessary for the tubule cells
homeostasis are not fully understood.
E3-ubiquitin ligase murine double minute-2 (MDM2) is the
master negative regulator of tumor suppressor gene p53 and a
non-redundant modulator of NF-ĸB signaling.4,5 As such
MDM2 amplification or overexpression drives tumor growth
and MDM2 blockade suppresses cancer development.6,7 In
acute kidney injury caused by primary glomerular insults,
MDM2 rather fosters podocyte demise by driving the
podocytes into mitosis, pushing them to bypass the G2/M
checkpoint that is, mitotic catastrophe.8 Moreover, by facilitat-
ing the NF-ĸB signaling, MDM2 promotes glomerular inflam-
mation in injured glomeruli and thus further aggravates the
podocyte loss, endothelial damage and glomerulosclerosis.9
In acute tubular injury MDM2 exacerbates the initial damage
phase via NF-ĸB-related inflammation but promotes regen-
eration in the later healing phase via p53 regulation.10 In
podocyte homeostasis MDM2 functions as a crucial factor
protecting podocytes from p53 overactivation related cell
death contributing thus to the lifelong survival of podocytes.11
Resting tubular epithelial cells express high levels of MDM2
and we hypothesized that quiescent tubular epithelial cells
require MDM2 to maintain the homeostasis. To address this
hypothesis we depleted the MDM2 or both MDM2 and p53 in
cultured murine tubular epithelial cells and in primary tubule
cells and in the mouse model by generating the tubular
epithelial cells-specific knockouts.
Results
MDM2 prevents tubular epithelial cell death in vitro. The
knockdown (KD) of MDM2 in mouse tubular epithelial cell line
with siRNA resulted in decreased viability of tubular cells in
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comparison to tubular cells treated with control siRNA
(Figure 1a). MDM2 suppression was associated with a
marked increase in p53 and p53 effector genes p21 and
PUMA transcript levels (Supplementary Figure 1A). The
concomitant KD of MDM2 and p53 significantly improved the
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This result was confirmed in primary tubular cells MDM2 KO
pTECs isolated from Pax8rtTa-cre; MDM2f/f mice, where
MDM2 was depleted specifically in tubular epithelial cells
in vitro by treatment with doxycycline. The generation of
theses mice is described below. MDM2 mRNA levels
decreased significantly in MDM2 KO pTECs treated with
1μg doxycycline (Figure 1b). The Mdm2-deficient primary
tubular cells showed increased expression of tubular damage
markers KIM-1, NGAL and TIMP-2 as well as increased cell
death, due to the upregulation of p53 (Figure 1b). Increased
p53 activity was confirmed by elevated mRNA expression of
p53-target genes p21 and PUMA (Supplementary Figure 1B).
The simultaneous depletion of MDM2 and p53 completely
rescued the viability of the primary tubular cells (Figure 1b).
The pTECs population was about 95% pure as assessed by
staining for the tubular epithelial cell markers cytokeratin-7
and E-cadherin (Figure 1c). To prove the specificity of MDM2
depletion in tubular epithelial cells, we isolated also parietal
epithelial and mesangial cells from kidneys of Pax8rtTA-cre;
MDM2f/f, treated them with doxycycline, and checked mRNA
levels of MDM2 and viability of those cells. Unlike in primary
tubular cells, MDM2 expression and viability remained
unchanged in the glomerular cells in comparison to the
controls (Supplementary Figure 1C). Ultrastructural analysis
of murine primary tubular cells lacking MDM2 revealed
vacuolization of cytoplasm, nicks in the cytoplasmic mem-
brane, and eventually cell death with complete disassembly
of the cell structure (Figure 1d). These results suggest that
MDM2 is required to protect the tubular cells from p53
overexpression-related cell death.
Mdm2 KD in zebrafish larvae induces cell death of renal
tubular epithelial cells. To validate the in vitro results
in vivo, a KD of mdm2 was generated in zebrafish larvae by
the injection of specific morpholinos into fertilized eggs and
was confirmed by qRT-PCR (Figure 2a). At 4 days post
fertilization (d.p.f.), the mdm2 KD zebrafish larvae developed
pericardial edema (white arrow in Figure 2b), a hallmark of
kidney failure, in contrast to control morpholino-injected
larvae (Ctrl) and larvae with a double KD knockout of
mdm2 and p53 (mdm2/p53). For a rapid screening of the
glomerular filtration barrier function, we used the transgenic
zebrafish strain CADE12 that expresses the eGFP-labeled
protein of the albumin family gc (group specific component) in
the blood which is unable to pass the healthy filtration barrier.
In Figure 2b, it is shown that the KD of mdm2 resulted in
larvae with reduced eGFP fluorescence in the vessels
indicating a leakage of the filtration barrier. To investigate
the morphology of pronephric tubules after the KD of mdm2,
we used the zebrafish strain Tg(wt1b:eGFP) that expresses
eGFP in podocytes, parietal epithelial cells and proximal
tubule cells.13 Sections of zebrafish larvae revealed a
significant dilatation of the pronephric tubules in mdm2 KD
larvae (Figure 2c) which could be rescued to some extent by
the KD of p53. Additionally, we have found less epithelial cells
in the proximal tubules after the mdm2 KD compared with Ctrl
and mdm2/p53 KD larvae (Figure 2c). The TUNEL assay
demonstrated that this is due to an increase of dead cells in
mdm2 KD larvae (Figure 2d). Furthermore, the remaining
cells showed a reduced expression of the Na+–K+–ATPase, a
marker of differentiated tubular epithelial cells (Figure 2c).
In vivo imaging of the pronephros of living Tg(wt1b:eGFP)
larvae by two-photon microscopy (2-PM) confirmed the
significant dilatation of the Bowman space after mdm2 KD
(asterisk in Figure 2e; Supplementary Movie 1) in contrast to
mdm2/p53 and Ctrl KD larvae (Supplementary Movies 2
and 3). We have found that the maximum width of the
pronephric proximal tubules in living zebrafish larvae sig-
nificantly increased from 7.03 μm (S.E.M.=2.29 μm, n=7) in
Ctrl and 8.53 μm (S.E.M.=2.19 μm, n= 7, P=0.01) in mdm2/
p53 KD larvae to 14.67 μm (S.E.M.=2.42 μm, n= 9,
P= 0.044) in mdm2 KD larvae (Figure 2f). These results show
that mdm2 is essential for pronephric tubular epithelial cells by
protecting them from a p53-dependent cell death.
MDM2 depletion in tubular epithelium results in acute
kidney injury. To confirm these findings in the mammalian
kidney, we crossed Pax8rtTA-cre mice with MDM2f/f mice to
generate a mice model with inducible MDM2 deletion
exclusively in renal tubular epithelial cell upon doxycycline
treatment, Pax8rtTA-cre;MDM2f/f (Figure 3a). These mice
were born at expected Mendelian ratios and did not show any
functional or renal histological abnormalities within 6 months
of age. Real-time PCR analysis of kidney extracts from
Pax8rtTA-cre;MDM2f/f mice treated with doxycycline
(MDM2− /− tubulus) for 4, 8 or 11 days demonstrated progres-
sively declining levels of MDM2 mRNA compared with control
mice (Figure 3b). MDM2 immunostaining was selectively
diminished in the renal tubular cells of the Pax8rtTA-cre;
MDM2f/f mice treated with doxycycline (MDM2− /− tubulus)
while the MDM2 immunostaining remained intact in the
glomerulus, confirming thus the selectivity of the MDM2
tubular deletion (Figure 3c; Supplementary Figure 2A).
MDM2− /− tubulus mice showed progressive impairment of
kidney function in comparison to control mice, as documen-
ted by significant increase of plasma creatinine and blood
Figure 1 MDM2 knockdown/knockout in murine tubular cell line and in primary tubular cells. (a) Murine tubular epithelial cells were incubated for 24 h with MDM2 siRNA or
control scrambled siRNA and MDM2 and p53 mRNA expression was measured by RT-PCR. The viability was assessed by MTTassay. (b) Primary tubular epithelial cells (pTEC)
were isolated from Pax8-rtTAcre;MDM2f/f (MDM2KO pTECs) or Pax8-rtTAcre;MDM2f/f;p53f/f (MDM2/p53dKO pTECs) mice and treated with doxycycline to induce MDM2 or
MDM2/p53 knockout. mRNA expression of MDM2, p53 and tubular damage markers KIM-1, NGAL and TIMP-2 was determined by RT-PCR. Cell viability and cell death were
measured by MTTand LDH assays. CTRL pTECs were isolated from MDM2fl/fl mice. CTRL pTECs treated with 2% Triton X were used as positive control. (c) Representative
confocal microscopy pictures of pTECs stained for markers of tubular epithelial cells cytokeratine-7 and E-cadherin used to assess the purity of the cell isolates. (d) Electron
microscopy images of control and MDM2KO pTECs treated with doxycycline. The MDM2-depleted pTECs undergo cell death associated with prominent cytoplasmic
vacuolization, cell membrane breaks and finally with the complete disassembly of the cell structure. All experiments were performed in triplicate. Data are means±S.E.M.
* Po0.05, **Po0.01, ***Po0.005. N, nucleus; M, mitochondria; V, vacuole
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urea nitrogen (BUN) levels (Figure 3d). Measured glomerular
filtration rate (GFR) declined from day 4 of doxycycline
treatment in MDM2− /− tubulus mice and at day 8 the mice were
severely oliguric compared with control littermates
(Figure 3e). The decline of MDM2− /− tubulus mice kidney
function was also associated with the shortened lifespan
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(Figure 3e). Also the renal mRNA levels of p53 and its
effector genes p21 and PUMA and tubular damage markers
KIM-1, NGAL and TIMP-2 had increased with the length of
doxycycline treatment (Figure 3f; Supplementary Figure 2B).
On light microscopy the kidneys of MDM2− /− tubulus mice
appeared normal at 4 days of doxycycline treatment while on
day 8 profound tubular epithelial cells swelling and their
vacuolization were apparent (Figure 4a). At day 11 of the
doxy treatment the kidneys displayed massive tubular dilation
with tubular cell flattening, damage and cell loss and
multifocal tubular granular casts (Figure 4a). Although the
MDM2 deletion in tubular epithelial cells affected both
proximal and distal tubuli as well as collecting ducts, the
proximal tubuli exhibited the highest damage with the loss of
almost 80% of the proximal tubular cells as determined by
staining for Lotus tetragonolobus lectin (Figure 4b). Analysis
of the kidneys of MDM2− /− tubulus mice by electron micro-
scopy detected ultrastructural abnormalities in tubular
epithelial cells such as swelling of the cytoplasm, endoplas-
mic reticulum changes, swelling of the mitochondria with the
loss of cristae and their transformation in the vacuoles
(Figure 5a). The nuclei were edematous but with no
membrane rupture and they did not appear to have
consolidated chromatin (Figure 5a). These abnormalities
suggest that the tubular epithelial cells undergo a stage of
asphyxia and start dying from the cytoplasm with dead
mitochondria. Eventually, the tubular epithelial cells comple-
tely disintegrate, the plasma membrane ruptures, and the
nuclei are released together with other cytoplasmic orga-
nelles (Figure 5a). Lack of MDM2 in tubular epithelial cells
was associated with the progressive increase of p53
expression and its nuclear shift. Simultaneously we observed
also the Ki-67 activation, suggesting the hypertrophy or
proliferation of undamaged tubular epithelial cells with
incomplete MDM2 deletion or of the tubular progenitors
(Supplementary Figure 3A). Nevertheless, the regenerating
tubular cells were not able to compensate for the cellular loss
due to p53 overactivation. TUNEL as well as cleaved
caspase-3 staining showed just marginal caspase-3 activa-
tion in the tubular compartment, mostly in the kidneys with
marked p53 upregulation and massive tubular cell death
(Figure 5b; Supplementary Figure 3B). The caspase-3
activation level does not correspond to the extent of the
kidney damage and is suggestive of secondary cell
apoptosis. We conclude that MDM2 is essential for tubular
epithelial cells homeostasis and survival and prevents acute
kidney injury.
The MDM2 deleterious phenotype in tubular epithelium is
p53 dependent. To test for the role of p53 in the structural
and functional renal pathology of MDM2− /− tubulus mice, we
generated inducible tubular epithelial cell-specific simulta-
neous MDM2 and p53 knockout mice MDM2/p53dKO tubulus
and the littermate controls with one p53 allele intact
MDM2− /− tubulus /p53wt/fl. We treated the both mouse lines
with doxycycline to induce the deletion of the respective gene
alleles. The analysis of the functional and histological
parameters of the mice models confirmed that the depletion
of p53 rescues the pathological phenotype of the
MDM2− /− tubulus mice (Figures 6a–e).
Tubular epithelium compensates only partially for the cell
loss caused by MDM2 depletion. Previously, it was
reported that mice lacking Mdm2 in the intestinal epithelium
can fully compensate for the MDM2 depletion/p53 activation-
mediated cellular loss because of negative selection of the
MDM2 transgenic cells and rapid proliferation and overgrowth
of cells with insufficient Cre recombinase activity and thus
incomplete MDM2 depletion.14 To investigate whether this
phenomenon occurs also in renal tubular epithelium, which is
known for its fast regenerative capacity, we subjected the
Pax8rtTA-cre; MDM2f/f mice to different doxycycline treat-
ment regimens to avoid the rapid lethality of the continuous
doxycycline treatment. We treated the mice with doxycycline
for 2 days to deplete the MDM2 just in the portion of the
tubular epithelial cells and repeated the treatment after 5 days
of recovery for three times. The renal function of the
experimental mice was impaired compared with the control
mice as documented by elevated serum creatinine and BUN
levels (Figure 7a) but the lifespan of the experimental animals
was not affected (data not shown). The histological analysis
showed focal tubular damage with overproduction of extra-
cellular matrix, suggesting that the loss of tubular cells is only
partially recovered by surviving tubular cells but rather
mesenchymal repair occurs (Figure 7b). Masson trichrome
staining confirmed the accumulation of the fibrotic tissue in
the kidneys of experimental mice (Figure 7b) and also mRNA
expression levels of several pro-fibrotic genes were elevated
(Figure 7c). We detected moderate p53 activation with
nuclear shift throughout the tubular compartment with
especially high expression in medullar region of the kidney
(Figure 7b). We conclude that unlike intestinal epithelium,
tubular epithelial cells cannot completely compensate for the
cells lost due to the MDM2 deletion.
Figure 2 Mdm2 knockdown in zebrafish larvae. (a) After the treatment of fertilized zebrafish eggs with mdm2 MO, mdm2/p53MO, mRNA expressions of mdm2 or both mdm2
and p53 were significantly reduced in contrast to larvae treated with Ctrl MO. The target mRNA expression levels were determined by real-time RT-PCR and expressed as mean of
the ratio versus the respective ctrb1 mRNA level±S.E.M. Data are means±S.E.M. ***Po0.005. (b) CADE larvae developed pericardial edema (white arrow) after the mdm2
KD in contrast to control morpholino-injected larvae (Ctrl) and mdm2/p53 morpholino-injected larvae. Mdm2 KD larvae showed a loss of the vascular eGFP fluorescence (green
arrow) due to a leaky filtration barrier. Scale bar represents 50 μm. (c) Paraffin sections were stained with H&E and an antibody against Na+/K+–ATPase, respectively. Glomerulus
(G), proximal tubule (P.T). Scale bar represents 20 μm. (d) TUNEL assay showed dead cells in the pronephric tubules of mdm2 KD larvae. Scale bar represents 20 μm. (e) 3D
reconstructions of 2-PM z-stack showed dilated pronephric proximal tubules in mdm2 KD larva. Scale bar represents 20 μm. (f) The box plot histogram shows the significant
dilatation of pronephros proximal tubule lumen of mdm2 KD larvae compared with Ctrl and mdm2/p53 KD larvae. Scale bar 20 μm
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Discussion
We hypothesized that MDM2 is important for homeostasis of
resting tubular epithelial cells in kidney. In the cell culture
experiments the tubular epithelial cells lacking MDM2 showed
decreased viability. The mouse model with the specific
deletion of MDM2 in tubular epithelial cells displayed
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documented by reduced GFR and increased plasma creati-
nine and BUN. We also detected significant upregulation of
tubular damage markers and massive swelling, mitochondrial
degeneration and cell death in the tubular compartment in the
kidneys of the experimental animals. All these changes
developed in unchallenged kidney and were consistent with
acute tubular injury. The tubular epitheliumwas not able to fully
compensate for the cell loss due to the MDM2 depletion by
proliferation of remaining tubular cells with intact MDM2 but
rather mesenchymal healing with fibrosis occurred. The
pathological phenotype was completely rescued by
co-deletion of p53. We conclude that MDM2 is essential for
survival and homeostasis of intact tubular cells in healthy
kidney.
MDM2, the main negative regulator of p53 suppresses its
function in three different ways; it chaperons p53 out of the
nucleus, that is, out of the transcriptional centrum, it blocks the
transcription of p53 effector genes and it ubiquitinates p53 and
targets it for proteasomal degradation.4 Through the p53
inhibition, MDM2 fosters cell proliferation and prevents p53-
mediated cell death, cell cycle arrest and senescence.15 This
MDM2 function is indispensable for the embryonic develop-
ment, wound healing and regeneration16 but it also facilitates
autoimmune disorders, such as lupus erythematosus17 and
carcinogenesis.18,19 MDM2 is overexpressed frequently in
many human tumors, especially in breast cancer and
sarcomas.20 The inhibitors of MDM2 and p53 binding are
being currently tested in clinical trials as potential cancer
therapy.21,22 Nevertheless also MDM2 depletion has deleter-
ious effects as documented by embryonic lethality of a mouse
model with genetic-deletion of MDM2. The mouse embryos
die due to the uncontrolled p53-dependent cell death, while
p53 deficiency completely rescues this deleterious
phenotype.23,24 Specific deletion of MDM2 in developing
kidney results in impairment of renal progenitor cell expansion,
in aberrant nephrogenesis and differentiation and leads to
hypodysplasia of the kidneys.25–27 Our data are in line with
these studies and show that MDM2 is crucial for the survival
and homeostasis of unchallenged tubular epithelial cells in
kidney. MDM2 prevents p53-mediated cell death of these renal
cells. Our findings differ from a study which showed that
unbuffered p53 activity caused by MDM2 deletion is detri-
mental only in radiosensitive tissues due to the massive cell
loss, while the radio-insensitive tissues, including kidney, are
protected from cell death but exhibit inhibition of cell
proliferation.28 Our data indicate that MDM2 depletion in
tubular epithelial cells leads to massive cell death due to p53
overactivation but proliferation activity is maintained as
documented by increased expression of Ki-67, marker of
proliferation. Our results are corroborated by another study
showing that global MDM2 deletion results in morphological
and functional abnormalities in both radiosensitive and radio-
insensitive tissues, including kidney.14 Renal phenotype
included initially just mild damage with no aberrant functional
effect, but subsequently the kidneys exhibited severe injury
with impairment of renal function.14 Further on,MDM2deletion
in intestinal epithelial cells results in multiple intestinal
abnormalities in newborn animals.29 These abnormalities
completely disappeared in adulthood due to the selection
against the enterocytes lacking MDM2 and increased
proliferation of the epithelium with intact MDM2.29 Although
the renal tubular epithelium has an extensive regenerative
capacity, our findings indicate that in kidneys of tubular specific
depleted MDM2 mice the complete epithelial healing does not
occur and is compensated by mesenchymal healing with
extensive fibrosis. This suggests that the inhibition of MDM2
could lead to acute kidney injury and due to incomplete healing
contribute to development of chronic kidney disease.30 In our
previous studies we showed that MDM2 in acute kidney injury
promotes tubular injury in early postischemic phase via
augmentation of NF-kB signaling and thus inflammation in
p53-independent manner.10 Our present data document, that
all renal anomalies due to MDM2 depletion in unchallenged
tubular epithelial cells are dependent on p53 activity, as the
defects completely disappeared when p53 was absent. This is
in line with studies which showed dose-dependent attenuation
of tubular cell death and kidney injury in mouse model of
cisplatin induced nephrotoxicity treated with p53 siRNA or with
chemical inhibitor of p53.31,32
Together, MDM2 is crucial in intact tubular epithelial cells in
kidney to prevent spontaneous p53 overactivation dependent
cell death and thus prevent acute tubular injury. As MDM2
antagonists are being developed as an alternative treatment to
chemotherapy for cancer treatment, it is of note that MDM2
inhibition might be detrimental for normal tissues, especially
for kidney as our data suggest. We conclude that MDM2 is
essential for survival and homeostasis of tubular epithelium in
kidney.
Materials and Methods
Cell culture experiments. Murine tubular epithelial cells (mTECs cell line)
were maintained in DMEM medium supplemented with 10% fetal bovine serum and
1% penicillin/streptomycin.The primary tubular cells (pTECs) were prepared from
renal cell suspensions as previously described.33 In brief, 4 weeks old Pax8-rtTAcre;
MDM2f/f or MDM2f/f control mice were used for renal cell extraction. Decapsulated
kidneys were diced and digested in 1 mg/ml collagenase A (Roche Diagnostics,
Mannheim, Germany) for 30 min at 37 °C and then passed through 70 μm pore
sieve (BD, Franklin Lakes, NJ, USA), washed, and diluted in 2 ml of PBS.
Separation of the tubular segments was achieved through Percoll (31%)
Figure 3 Tubular cell-specific MDM2 knockout in mouse model results in acute kidney injury with fast decline of renal function. (a) Mice expressing inducible cre recombinase
under control of Pax8 promoter were crossed with MDM2fl/flmice to generate tubular cell-specific MDM2 knockout mice. (b) RT-PCR analysis confirmed suppression of MDM2
mRNA expression in kidney lysates of Pax8rtTA-cre;MDM2f/f mice treated with doxycycline. (c) Immunohistochemical staining confirmed MDM2 deletion in tubular cells while in
podocytes in glomerulus the MDM2 expression remained unchanged. (d) Pax8rtTA-cre;MDM2f/f mice treated with doxycycline developed increasing elevation of plasma
creatinine and plasma BUN (n= 5–6 mice in each group). (e) Left: GFR measurement showed significant decrease of GFR from day 6 of doxycycline treatment in Pax8rtTA-cre;
MDM2f/f mice while the GFR of control MDM2f/f mice was unaffected. Right: Kaplan–Meyer survival curve of MDM2− /− tubulus and control mice (n= 17 per group). (f) mRNA
expression of p53 as well as of tubules damage markers KIM-1, NGAL and TIMP-2 was increasingly elevated in MDM2− /− tubulus mice kidneys in comparison to control mice
kidneys. Data are means± S.E.M. *Po0.05, **Po0.01, ***Po0.005
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Figure 4 Tubular injury in tubular cell-specific MDM2 knockout mice kidneys. (a) Representative images of PAS-stained kidney sections at a magnification 200x from
Pax8rtTA-cre;MDM2f/f and control mice treated for 4, 8 or 11 days with doxycycline showing the progressive aggravation of tubular injury. At day 4 was no tubular damage
apparent, at day 8 the tubular cells swelling and vacuolization were the prominent pathologic features and at day 11 the global tubular damage with massive cell loss, tubular
dilation and tubular casts was detected. Tubular injury was quantified on PAS-stained renal section as described in Materials and methods. (b) Lotus tetragonolobus lectin staining
identified proximal tubuli, Tamm-Horsfall protein (THP) staining identified distal tubuli and Aquaporin 2 identified the collecting ducts in Pax8rtTA-cre;MDM2f/f and control mice
kidneys treated for 4, 8 or 11 days with doxycycline. The quantitative assessment of tubuli with intact staining patterns is shown for each staining. Data are means± S.E.M. from
six mice in each group. *Po0.05, **Po0.01, ***Po0.005. All images are shown at a magnification of × 100
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Figure 5 Ultrastructural pathology in tubular cell-specific MDM2 knockout mice tubular cells. (a) Electron microscopy at 4 days of MDM2 depletion reveled an onset of
cytoplasmic swelling, at 8 days pronounced cytoplasmic swelling with occasional cytoplasmic membrane rupture but intact nuclei and at 11 days a complete degradation of the
tubular cell structure with vacuolization of swollen cytoplasm, massive degeneration of mitochondria, edematous nuclei and release of the cell content into the tubular lumen. (EM
in successive low–medium–high 1500–12 000 magnification). (b) Representative pictures of kidney sections from Pax8rtTA-cre;MDM2f/f and control mice kidneys treated for 4, 8
or 11 days with doxycycline showing staining for activated caspase-3, marker of apoptosis, Ki-67, marker of proliferation or hypertrophy and p53, marker of the cell cycle arrest,
senescence and cell death. All images are shown at a magnification of × 100. Bb, brush border; BL, basal lamina; L, lysosome; M, mitochondria; N, nucleus
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Figure 6 Simultaneous MDM2 and p53 tubular cell-specific knockout rescues the pathological phenotype in MDM2/p53dKO tubulus mouse model. (a) Total mRNA was
prepared from kidneys isolated from MDM2− /− tubulus /p53wt/flor MDM2/p53dKO tubulus mice respectively and control MDM2fl/flmice treated for 11 days with doxycyclin. The target
mRNA expression levels were determined by real-time PCR and expressed as mean of the ratio versus the respective 18S mRNA level± S.E.M. (b) Serum creatinine and BUN
measurement in plasma of MDM2/p53dKO tubulus and positive control MDM2− /− tubulus /p53wt/flmice treated for 11 days by doxycycline (n= 10 in each group). (c) Kaplan–Meyer
survival curve of MDM2/p53dKO tubulus and control MDM2− /− tubulus /p53wt/flmice (n= 10 in each group). (d) Representative images of PAS and p53 stained kidney sections from
MDM2/p53dKO tubulus and control MDM2− /− tubulus /p53wt/flmice treated for 11 days with doxycycline. All images are shown at a magnification of × 200. (e) Real-time PCR analysis
of renal tubular damage markers KIM-1, NGAL and TIMP-2 mRNA prepared from kidneys isolated from MDM2/p53dKO tubulus and positive control MDM2− /− tubulus /p53wt/flmice
treated for 11 days with doxycycline. Data are means±S.E.M. ***Po0.005
MDM2 in tubular epithelial cell homeostasis
D Thomasova et al
10
Cell Death and Disease
centrifugation at 3000 r.p.m./10 min/4 °C. The pellet of tubular segments was
collected and washed twice with PBS at 1500 r.p.m./5 min/4 °C. The renal tubular
cell isolates were cultured under sterile conditions at 37 °C and 5% CO2 in
conditioned medium consisting of DMEM w/glucose (Gibco/Life Technologies,
Grand Island, NY, USA), 10% fetal bovine serum (Biochrom, Berlin, Germany), 1%
penicillin/streptomycin (PAA Laboratories, Pasching, Austria), HBSS (Sigma-Aldrich,
Steinheim, Germany), HEPES (Gibco/Life Technologies, Grand Island, NY, USA),























































































































































Figure 7 Tubular epithelium compensates only partially for the cell loss caused by MDM2 depletion. To induce a sub-lethal deletion of MDM2 in tubular epithelial cells in our
mouse kidney model we treated Pax8rtTA-cre;MDM2f/fmice intermittently with 2 mg/ml doxycycline for 4 weeks. (a) Pax8rtTA-cre;MDM2f/fmice treated with intermittent regimen
of doxycycline had elevated plasma creatinine and plasma BUN at 4 weeks (n= 5–6 mice in each group). (b) Representative images of kidney sections from controlMDM2f/f and
Pax8rtTA-cre;MDM2f/fmice treated for 4 weeks intermittently with doxycycline and stained with PAS, Masson trichrome and p53 antibody. All images are shown at a magnification
of × 200. (c) Real-time PCR analysis of pro-fibrotic genes mRNA prepared from kidneys isolated from experimental and control mice treated for 4 weeks with doxycycline. Data
are means±S.E.M. *Po0.05, **Po0.01, ***Po0.005
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(Roche Diagnostics, Mannheim, Germany). For the assessment of the purity of the
pTECs population were the cells grown in the 8-well chamber slides to confluency,
than fixed in ice-cold acetone, stained for the markers of the tubular epithelial cells
cytokeratin-7 and E-cadherin and TOPRO for nuclei and analyzed with confocal
microscopy. For the viability assays, the mouse mTECs or primary TECs
were seeded in 96 well plates (8000 cells/well), for the RNA extraction the mTECs
and pTECs were cultured in 6-well plates (200 000 cells/wellThe mTECs were then
incubated with 25nM siRNA for 24–48 h using Lipofectamine RNAiMAX transfection
reagent (Life Technologies, Darmstadt, Germany) for transient transfection.
Specific siRNA to silence selectively MDM2 or p53 as well as appropriate control
siRNA (Negative control No.1) was purchased from Ambion (Life Technologies).
The pTECs isolated from Pax8-rtTAcre;MDM2f/f or MDM2f/f control mice were
treated for 48 h with 1μg/ml doxycycline to induce MDM2 depletion. The TECs or
the pTECs were collected, 24–48 h post-treatment for RNA isolation or for
cytotoxicity/viability assays that were performed using LDH assay
(Cytotoxicity Detection Kit (LDH), Roche, Mannheim, Germany) and MTT assay
(CellTiter 96 Non-Radioactive Cell Proliferation Assay, Promega, Madison, WI, USA)
according to manufacturer´s instructions. Experiments were performed in
triplicate.
Zebrafish experiments:. Zebrafish strains and larvae were maintained as
described previously.34 The following zebrafish strains were used: CADE
(Tg (−3.5 fabp10a:gc-eGFP) mitfaw2/w2; roya9/a9) which expresses a gc-eGFP
fusion protein in the blood plasma.12 The (Tg(wt1b:eGFP)) strain that expresses
eGFP under control of the wt1b promotor.13 The following morpholinos were used:
mdm2 MO: 5′-AACAACTCTCTGTTGCCATTTTGGT-3′; p53 MO: 5′-GCGCC
ATTGCTTTGCAAGAATTG-3′; Crtl MO: 5′-CCTCTTACCTCAGTTACAATTTATA-3′.
MOs were diluted to a concentration of 0.3 nM. A volume of ~ 3 nl per zebrafish egg
was injected into the yolk at the one- to four-cell stage using a microinjector
(Transjector 5246; Eppendorf, Germany). For histological staining, we followed our
previously published protocols.12 Anti-A6f antibody (1:25, Sigma-Aldrich) was used.
2-PM experiments: To prevent pigmentation, the zebrafish larvae were subjected to
E3 medium supplemented with 0.003% phenylthiourea at 1 d.p.f. For in vivo imaging
experiments, zebrafish larvae were embedded in 0.8% low-melting agarose
(Biozym LE agarose, Germany) in E3 medium in a dorsal side up position. After
hardening the larvae were covered with E3 medium supplemented with 0.06 mg/ml
Tricaine (Sigma-Aldrich, St Louis, MO, USA). All 2-PM experiments were performed
at 22 °C. Z-stacks of pronephric glomeruli and proximal tubules were recorded over a
distance of 98 μm with a voxel volume of 0.30 × 0.30 × 2 μm and reconstructed as 3D
movies using the ZEN 2010 software (Carl Zeiss Microimaging, Jena, Germany) as
described before.35 For significance testing Gaussian distribution was checked by
Kolmogorov-Smirnov testing, followed by significance testing with Student’s t-test
using SPSS V.22 (IBM, Armonk, NY, USA). P-values below 0.05 were declared as
statistical significant. All experiments were performed in accordance with German
animal protection law overseen by the agencies of the Federal State of Mecklenburg -
Western Pomerania.
Mouse experiments. The Pax8-rtTAcre;MDM2f/f mice were generated by
breeding the MDM2flox/flox mice, in which loxP sites flanked the exon 4 and 5 of
MDM2 gene, with Pax8-rtTAcre mice, expressing the inducible Cre recombinase
under control of the Pax8 promoter. The MDM2flox/flox mice (/B6 mixed background)
were a generous gift from G. Lozano (University of Texas, Huston, USA) and the
Pax8-rtTA mice (C56Bl/6 background) were kindly provided by T. Huber (University of
Freiburg, Freiburg, Germany). Both mice strains were previously described.36,37 The
MDM2flox/flox littermates lacking the Pax8-rtTAcre transgene were used as control
mice. To generate the tubular epithelial cell-specific MDM2/p53 double
knockout Pax8-rtTAcre;MDM2f/f;p53f/f (MDM2/p53dKD tubulus) mice, we bred the
Pax8-rtTAcre;MDM2f/f mice with p53flox/flox mice, in which the loxP sites were inserted
in intron 1 and 10 to ensure Cre-mediated removal of nearly all coding sequences.38
The p53flox/flox mice were a generous gift from L. Rudolph (University of Ulm, Ulm,
Germany). The Pax8-rtTAcre;MDM2f/f;p53wt/f (MDM2− /−tubulus/p53wt/fl) littermates
were used as positive controls. To induce Cre recombinase expression, we treated
the mice with 2mg/ml doxycycline in drinking water supplemented with 5%
sucrose for various number of days as indicated in figures. All animal studies were
approved by the Committee on Research Animal Care, Regierungspräsidium
Oberbayern.
Renal function measurement: Plasma creatinine levels as well as BUN
(DiaSys GmBH, Holzheim, Germany) levels were determined using commercially
available kits as per manufacturer’s protocol.
GFR measurement: GFR was measured transcutaneously using a USB-device
according to manufacturer’s instructions (Mannheim Pharma&Diagnostics GmbH,
Mannheim, Germany). The USB-device was fasten with adhesive tape to the
shaved area on the mouse back. The mice were injected with FITC-Sinistrin i.v.
(15 mg FITC-Sinistrin/100 g body weight). The measurement was performed for
60 min and analyzed with software provided by the manufacturer.
Renal histology, immunohistochemistry, confocal microscopy and
electron microscopy: Kidney tissues were fixed in 4% neutral-buffered formalin,
dehydrated in graded alcohols and embedded in paraffin. For routine histology the
4 μm sections were stained with periodic acid-Schiff (PAS) reagent. For
immunohistochemistry sections were deparaffinized, rehydrated, transferred into
citrate buffer, and either autoclaved or microwave treated for antigen retrieval and
processed as described.10 For histochemistry we used biotinylated Lotus
Tetragonolobus Lectin stain (Vector Labs, Burlingame, CA, USA), Tamm-Horsfall
Table 1 Primers used for real-time RT-PCR
Target Primer sequence
MDM2 Forward primer 5′-TGTGAAGGAGCACAGGAAAA -3′
Reverse primer 5′-TCCTTCAGATCACTCCCACC -3′
p53 Forward primer 5′-TCCGACTGTGACTCCTCCAT-3′
Reverse primer 5′-CTAGCATTCAGGCCCTCATC-3′
KIM-1 Forward primer 5′-TGGTTGCCTTCCGTGTCTCT-3′
Reverse primer 5′-TCAGCTCGGGAATGCACAA-3′
NGAL Forward primer 5′-TGAACTTCTGAAAACGGCT-3′
Reverse primer 5′-AGCAGCAAGGGCACAAT-3′
TIMP-2 Forward primer 5′-CGTTTTGCAATGCAGACGTA-3′
Reverse primer 5′-GAATCCTCTTGATGGGGTTG-3′
TGF-β Forward primer 5′-GGAGAGCCCTGGATACCAAC-3′
Reverse primer 5′-CAACCCAGGTCCTTCCTAAA-3′
Fibronectin Forward primer 5′-GGAGTGGCACTGTCAACCTC-3′
Reverse primer 5′-ACTGGATGGGGTGGGAAT-3′
Collagen1a1 Forward primer 5′-ACATGTTCAGCTTTGTGGACC-3′
Reverse primer 5′-TAGGCCATTGTGTATGCAGC-3′
Collagen4a1 Forward primer 5′-GTCTGGCTTCTGCTGCTCTT-3′
Reverse primer 5′-CACATTTTCCACAGCCAGAG-3′
18s Forward primer 5′-GCAATTATTCCCCATGAACG-3′
Reverse primer 5′-AGGGCCTCACTAAACCATCC- 3′
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protein stain (Santa Cruz, CA, USA) and rabbit anti-mouse Aquaporin 2 (Abcam,
Cambridge, UK). Further on the following primary antibodies were used: rabbit
anti-mouse MDM2 (Abcam, Cambridge, UK), rabbit anti-mouse p53
(Vector Laboratories, Burlingame, CA, USA), rat anti-mouse Ki-67 (DakoCytoma-
tion, Glostrup, Denmark), rabbit anti-mouse cleaved caspase-3
(Cell signaling Technology, Denvers, MA, USA), mouse anti-mouse E-cadherin
(BD Biosciences, San Jose, CA, USA) and mouse anti-mouse cytokeratin-7
(Abcam). Immunofluorescent stainings were evaluated using a LSM 510 confocal
microscope and LSM software (Carl Zeiss AG). For transmition electron microscopy,
the kidney cortex was sectioned into 1x1mm cubes and immediately immersed in
fixative containing 3% glutaraldehyde and 1% paraformaldehyde in PBS.
Post-fixation kidneys were immersed in cold fixative containing 2% glutaraldehyde
and 2% paraformaldehyde in sodium cacodylate buffer (pH 7.4). Kidneys were
postfixed in phosphate cacodylate-buffered 2% OhsO4 for 1 h, dehydrated in
graded ethanols with a final dehydration in propylene oxide and embedded in
Embed-812 (Electron Microscopy Sciences, Hatfield, PA, USA). Ultrathin
sections (~90-nm thick) were stained with uranyl acetate and Venable's lead
citrate and viewed with a JEOL model 1200EX electron microscope (JEOL, Tokyo,
Japan).
Morphometry: To assess tubulointerstitial changes a semiquantitative score was
established to evaluate the degree and extent of tubulointerstitial damage of each
field and was graded from 0 to 4 as follows: 0 represents no lesion, 1 represents
tubulointerstitial damage of less than 25% per field, and 2, 3 and 4 represent
tubulointerstitial damage of 25–50%, 50–75% and more than 75% of the
tubulointerstitium, respectively. Approximately 30 cortical and medullary visual
fields (20 × ) per kidney were evaluated. Tubulointerstitial injury was defined by
features such as tubular collapse, cast formation with tubular dilatation or atrophy,
detachment of cells from the basement membrane.
RNA preparation and real-time quantitative PCR. Total RNA was
extracted from mouse glomeruli, isolated using Dynabead perfusion, or murine
podocyte cell line using Ambion RNA extraction kit (Invitrogen, Carlsbad, CA, USA)
following the manufacturer’s instructions. After quantification, RNA quality was
assessed using agarose gels before reverse transcriptionwith Superscript II
(Invitrogen) as described.39 Real-time RT-PCR was performed using SYBRGreen
PCR master mix and analyzed with a Light Cycler 480 (Roche). All gene expression
values were normalized using 18s RNA as a housekeeping gene. All primers used
for amplification were from Metabion (Martinsried, Germany). Primers used are
listed in the Table 1.
Statistical analysis. Values are expressed as mean±S.E.M. Statistical
analysis was performed using Graphpad Prism5 software (GraphPad Software, La
Jolla, CA, USA). Significance of differences was determined by the appropriate
two-sided t-test for single comparisons. Analysis of variance (ANOVA) with post hoc
Bonferroni's correction was used for multiple comparisons. P -values o0.05 were
considered statistically significant.
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